The Injectrode® Platform aims to provide chronic pain patients with an easy way to get relief without drugs or invasive surgeries.
Location: United States
Total raised: $4.5M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.10.2025 | - | $4.5M | - |
Mentions in press and media 5
| Date | Title | Description |
| 15.10.2025 | Neuronoff Secures $4.5M to Revolutionize Pain Management | Neuronoff raised $4.5M to propel its Injectrode platform toward FDA clearance and 2026 commercial launch. This minimally invasive medical device offers drug-free chronic pain treatment, eliminating surgery and visible scars. It employs the ... |
| 14.10.2025 | Neuronoff: $4.5 Million Secured For Developing Minimally Invasive Pain Treatments | Neuronoff, a medical device company focused on developing minimally invasive treatments for pain, has closed an oversubscribed financing round, raising $4.5 million. This funding is expected to propel the company’s Injectrode platform towar... |
| 08.10.2025 | Neuronoff Closes $4.5M Funding | Neuronoff, a Cleveland, OH-based clinical-stage medical device company, raised $4.5M in funding. Bakcers ere not disclosed. The company intends to use the funds to advance its Injectrode platform toward FDA clearance and commercial launch. ... |
| 23.04.2024 | Neuronoff Announces Safety and Functionality Success in First-in-Human Trial of Injectrode for Minimally Invasive Chronic Pain Relief (LIFE study) | CLEVELAND, April 23, 2024 /PRNewswire/ -- Neuronoff, Inc., a pioneering medical device company dedicated to developing minimally invasive neuromodulation solutions, announced a significant milestone in its mission to transform chronic pain ... |
| - | Neuronoff | “The Injectrode® Platform aims to provide chronic pain patients with an easy way to get relief without drugs or invasive surgeries.” |